Related Experiment Videos
Collaborative Transplant Study Kidney Exchange Trial for highly sensitized recipients
1Department of Transplantation Immunology, University of Heidelberg, Germany.
Clinical Transplants
|January 1, 1991
Summary
Highly sensitized patients achieve over 70% 1-year kidney transplant success. Optimal human leukocyte antigen (HLA) matching, especially for HLA-DR and HLA-B, significantly improves graft survival rates.
Area of Science:
- Nephrology
- Immunology
- Transplantation Science
Background:
- Kidney transplantation is a vital treatment for end-stage renal disease.
- Highly sensitized recipients present a significant challenge due to pre-formed antibodies.
- Optimizing graft survival in this population requires careful donor selection.
Purpose of the Study:
- To evaluate the impact of human leukocyte antigen (HLA) matching on kidney transplant outcomes in highly sensitized recipients.
- To identify specific HLA loci that most influence graft success in this patient group.
Main Methods:
- Analysis of 1-year graft survival rates in highly sensitized patients undergoing first, second, third, or fourth kidney transplants.
- Correlation of graft success with the number of HLA-B and HLA-DR mismatches.
Main Results:
- First and second kidney transplants in highly sensitized recipients achieved over 70% 1-year graft success.
- Third or fourth transplants had a 25% lower success rate.
- Zero HLA-B and HLA-DR mismatches resulted in an 88% 1-year graft survival rate, highlighting the critical role of HLA matching.
Conclusions:
- HLA matching, particularly for HLA-DR and HLA-B, is crucial for successful kidney transplantation in highly sensitized individuals.
- The findings support the necessity of national and international kidney exchange programs to facilitate optimal HLA matching for these patients.